Risk of invasive fungal infections in patients with high‐risk MDS and AML receiving hypomethylating agents.

Published in:

American Journal of Hematology, 2020, v. 95, n. 7, p. 792, doi. 10.1002/ajh.25808

By:

• Kim, Gee Youn (Geeny);
• Burns, Jonathan;
• Freyer, Craig W.;
• Hamilton, Keith W.;
• Frey, Noelle V.;
• Gill, Saar I.;
• Hexner, Elizabeth O.;
• Luger, Selina M.;
• Mangan, James K.;
• Martin, Mary E.;
• McCurdy, Shannon R.;
• Perl, Alexander E.;
• Porter, David L.;
• Schuster, Mindy G.;
• Stadtmauer, Edward A.;
• Loren, Alison W.

Publication type:

Article